ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,1,Exostosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3,1,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
4,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
5,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
6,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
8,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8,2,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9,3,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
10,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
11,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
12,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
12,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
12,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
13,1,Femoral hernia,Femoral hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
14,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
15,1,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
16,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
17,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Catheter site haematoma,Implant and catheter site reactions,Administration site reactions,Genrl,N
18,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
18,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
21,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
21,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
21,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
23,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
23,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
25,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
25,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
25,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
25,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
26,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
27,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
27,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
29,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
30,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
32,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
33,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
34,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
34,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
34,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
35,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
36,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
37,1,Catheter site thrombosis,Implant and catheter site reactions,Administration site reactions,Genrl,N
38,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
38,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,3,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
38,4,Pelvic fluid collection,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
38,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
38,8,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
38,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,1,Mesenteric arteriosclerosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
40,2,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
41,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
42,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
42,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
43,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
44,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
44,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
44,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
45,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
46,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
46,2,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
47,1,Headache,Headaches NEC,Headaches,Nerv,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
50,1,Spontaneous haemorrhage,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
51,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
51,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
52,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
53,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
53,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
54,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
55,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
55,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
55,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
56,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
56,3,Traumatic fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
57,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
60,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
62,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
62,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
63,1,Anti factor VIII antibody positive,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
64,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,2,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
65,1,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
66,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
66,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
67,1,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
68,1,Headache,Headaches NEC,Headaches,Nerv,N
69,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
70,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
71,1,Headache,Headaches NEC,Headaches,Nerv,N
72,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
73,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
74,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
75,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
76,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
76,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
76,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
77,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
77,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
78,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
78,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
78,4,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
78,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
79,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
81,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
81,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
81,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
82,1,Headache,Headaches NEC,Headaches,Nerv,N
83,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Headache,Headaches NEC,Headaches,Nerv,N
84,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
85,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
87,1,Headache,Headaches NEC,Headaches,Nerv,N
88,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
89,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
91,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
92,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
92,3,Migraine,Migraine headaches,Headaches,Nerv,N
92,4,Procedural anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
92,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
94,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
95,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
96,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
97,1,Headache,Headaches NEC,Headaches,Nerv,N
97,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
98,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,2,Headache,Headaches NEC,Headaches,Nerv,N
98,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
100,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
100,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
101,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
101,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
101,3,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
101,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
101,6,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
102,1,Headache,Headaches NEC,Headaches,Nerv,N
103,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
103,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
103,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
103,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
104,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
105,1,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
106,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
107,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
108,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
109,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
109,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
110,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
111,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
112,1,Headache,Headaches NEC,Headaches,Nerv,N
113,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
113,2,Headache,Headaches NEC,Headaches,Nerv,N
113,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
113,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
114,1,Product intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
115,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
117,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
119,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
120,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
120,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
121,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
121,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
121,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
122,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
123,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
123,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
124,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
125,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
126,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
128,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
130,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
131,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
131,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
131,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
134,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
134,2,Headache,Headaches NEC,Headaches,Nerv,N
134,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
134,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
135,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
136,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
136,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
137,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
137,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
138,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
139,1,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
140,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
141,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
143,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
143,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
145,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
146,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
147,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
147,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
147,3,Headache,Headaches NEC,Headaches,Nerv,N
147,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
148,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
149,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
149,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
150,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
151,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
152,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
152,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
152,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
154,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
154,2,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
154,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
154,4,Headache,Headaches NEC,Headaches,Nerv,N
154,5,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
155,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
155,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
156,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
157,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
157,2,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
157,3,Mitral valve repair,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
158,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
159,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
160,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
161,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
162,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
164,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
165,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
165,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
166,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
167,1,Headache,Headaches NEC,Headaches,Nerv,N
167,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
167,3,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
168,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
169,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
171,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
172,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
173,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
174,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
175,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
176,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
177,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
